Trial Profile
Multicentre, open-labeled study of etanercept in the treatment of patients with ankylosing spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Wyeth
- 17 Apr 2007 New trial record.